Vivek Ramaswamy has made a name for himself as a successful biotech entrepreneur and conservative commentator.

TRexBio secured $84 million Series B funding, led by Delos Capital with Eli Lilly and Johnson & Johnson participating, to ...

To build out the facility and ensure the success of this new venture, QPS has hired Tia Hexom, PhD, (Senior Director of Cell ...

German drugmaker BioNTech has agreed to acquire Chinese biotech company Biotheus to support its oncology strategy and gain ...

Hera Biotech’s cofounders from left to right: Dr. Bruce Nicholson, Dr. Paul Castella, Somer Baburek, ... [+] & Dr Nameer ...

Trump shared Tuesday night that he chose both billionaire Elon Musk and biotech entrepreneur Vivek Ramaswamy to lead the ...

The agency has placed a partial hold on the phase 2a PORTOLA trial evaluating the selective immunoproteasome inhibitor ...

Vertex has reached a key moment because the U.S. Food and Drug Administration (FDA) is reviewing its candidate, suzetrigine, ...

with Trump adding that the SpaceX and Tesla founder will work with biotech investor Ramaswamy to give the White House ...

Appointed to lead the Department of Government Efficiency alongside Elon Musk, Indian-origin entreprenuer Vivek Ramaswamy's ...

COLUMBUS, Ohio—Ohio biotech entrepreneur Vivek Ramaswamy has been named by President-elect Donald Trump to co-run a new ...

Now, the biotech has struck a deal to gain full control of PM8002, a bispecific also known as BNT327. BioNTech is paying $800 ...